The clinical guideline for CG16 Self-harm in over 8s: short-term management and prevention of recurrence has been checked by NICE for the need for update.
Registered stakeholders for the guideline are invited to comment on the provisional decision via this website. Please see the consultation page for more details.
Review decision date: February 2014
Following consultation with stakeholders this guideline has now been placed on the static list.
Next review date: TBC
In November 2011 the following recommendations were replaced with recommendations from self-harm: longer-term management (NICE guideline CG133): recommendations 126.96.36.199 and 188.8.131.52 on assessment of risk, 184.108.40.206 on special issues for children and young people, and 220.127.116.11 on psychological, psychosocial and pharmacological interventions.
Recommendation 18.104.22.168 on psychological, psychosocial and pharmacological interventions was withdrawn.
The NICE clinical guideline on self-harm covers:
- the care people who harm themselves can expect to receive from healthcare professionals in hospital and out of hospital
- the information they can expect to receive
- what they can expect from treatment
- what kinds of services best help people who harm themselves
The guideline does not attempt to explain self-harm or describe the treatment in detail.
This guideline was previously called self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.